Related references
Note: Only part of the references are listed.The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar et al.
HAEMATOLOGICA (2017)
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar et al.
HAEMATOLOGICA (2017)
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+advanced systemic mastocytosis
M. Jawhar et al.
LEUKEMIA (2016)
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
M. Jawhar et al.
LEUKEMIA (2016)
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M. Jawhar et al.
LEUKEMIA (2015)
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis
Philipp Erben et al.
ANNALS OF HEMATOLOGY (2014)
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components
Sa A. Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab et al.
BLOOD (2013)
In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells
Erinn Soucie et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome
Iris Cordoba et al.
CANCER (2012)
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
Naseema Gangat et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis
Kebede Hussein et al.
BLOOD (2010)
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Ken-Hong Lim et al.
BLOOD (2009)
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
Animesh Pardanani et al.
BLOOD (2009)
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients
Detlef Haase et al.
BLOOD (2007)
Acute myeloid leukaemia with t(8;21) associated with ''occult'' mastocytosis. Report of an unusual case and review of the literature
HW Bernd et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Cytogenetic studies in patients with mastocytosis
B Swolin et al.
CANCER GENETICS AND CYTOGENETICS (2000)
Share Paper
